PRINCETON, NJ / ACCESSWIRE / May 6, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a biopharmaceutical company developing innovative targeted biologic drugs, will be participating in the EF Hutton Annual Global Conference, which will take place on May 15, 2024 at The Plaza Hotel in New York.
Sonnet Announces Data from the Company’s Phase 1b/2a Clinical Trial of SON-080
Sonnet Announces a Publication Demonstrating Safety of SON-1010
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview